Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Recurrence Rate of Keloid After Excision Between Intra-operative Steroid Injection and Steroid With Platelet-rich Plasma Injection Combination Therapy

NCT06965088 is registered in ClinicalTrials.gov with Ramathibodi Hospital as lead sponsor.

NCT NCT06965088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06965088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Recurrence Rate of Keloid After Excision Between Intra-operative Steroid Injection and Steroid With Platelet-rich Plasma Injection Combination Therapy
Lead sponsor
Ramathibodi Hospital
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 28, 2025
Completion date
September 30, 2026
Enrollment
212 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with keloid scar